Rare diseases
Investigational molecules
Locations
Placa D'alfonso Comin 5-7, 08023 Barcelona, Spain
Hospital Quironsalud Barcelona in Barcelona, Spain specialises in clinical trials of conditions such as Neoplasm, Neoplasm malignant, Non-small cell lung cancer, Breast cancer, and other specialisations. This site conducts important research.
The Instituto de Oncología de Barcelona includes a strong program in cardiovascular disease, evaluating new therapies to lower heart‑related events and improve blood pressure control.
With more than 120 active trials and 59 investigators, Hospital Quironsalud Barcelona is advancing preventive and treatment strategies for heart conditions.
Research at the site targets digestive system diseases, focusing on innovative treatments for gastrointestinal cancers and related disorders.
Trials explore targeted agents, immunotherapies, and combination regimens to increase survival and quality of life for patients with digestive tract malignancies.
The centre conducts studies in hemic and lymphatic diseases, aiming to improve outcomes for blood‑related cancers and disorders.
By testing novel antibodies and cellular therapies, investigators seek to enhance remission rates and reduce treatment toxicity.
A dedicated effort focuses on immune system diseases, including autoimmune conditions and immune‑modulating cancer therapies.
The program evaluates how modulating immune pathways can both treat malignancies and alleviate autoimmune disease activity.
The primary focus of the institute is on neoplasms, conducting extensive trials across a wide spectrum of solid tumors.
Trials range from early‑phase safety studies to late‑stage efficacy assessments, seeking better response rates, longer survival, and improved quality of life.
Studies in nutritional and metabolic diseases address metabolic syndrome, lipid disorders, and diabetes‑related complications.
By testing agents such as inclisiran, finerenone, and empagliflozin, investigators aim to reduce cardiovascular events and renal decline.
The site includes research on respiratory tract diseases, combining oncology and infectious disease approaches.
Clinical trials evaluate novel immunotherapies, antiviral vaccines, and supportive care strategies to improve lung health.
Research in virus diseases focuses on prevention and treatment of viral infections affecting vulnerable populations.
The program seeks to enhance immunity, reduce disease severity, and explore viral antigens as targets for cancer treatment.
Investigations of metabolism explore biochemical pathways that influence disease progression and treatment response.
By linking metabolic biomarkers to therapeutic outcomes, researchers aim to personalize interventions across multiple disease areas.
The institute also studies fundamental physiological processes that underlie health and disease.
Understanding these processes supports the development of therapies that restore normal function and improve patient outcomes.
Clinical trials currently enrolling participants at this site.
SpainSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
